This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.
RSA 318:67 · Definitions
318:67 Definitions. – In this subdivision: I. "Department" means the insurance department. II. "Manufacturer" means any entity which is engaged in the production, preparation, propagation, compounding, conversion, or processing of prescription drugs, whether directly or indirectly by extraction from substances of natural origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, or any entity engaged in the packaging, repackaging, labeling, relabeling, or distribution of prescription drugs. The term shall not include a wholesale distributor of prescription drugs, a retailer, or a pharmacist licensed under the board. III. "Prescription drug" means a drug defined in 21 U.S.C. section 321. Source. 2020, 4:1, eff. Jan. 1, 2020.
Source note
Source. 2020, 4:1, eff. Jan. 1, 2020.
Source history
- 2020, 4:1, eff. Jan. 1, 2020
Related materials
Bills affecting or mentioning this RSA
- 2026 HB1249 reference
- 2026 HB1584-FN amend · 2027-01-01
- 2026 SB504-FN reference · 2027-01-01
- 2026 SB665-FN amend · 2027-01-01
- 2025 HB254 reference
- 2025 HB63 reference